Renin-Angiotensin System Gene Polymorphisms, Blood Pressure,Dyslipidemia, and Diabetes in Hong Kong Chinese
Open Access
- 1 February 2001
- journal article
- Published by American Diabetes Association in Diabetes Care
- Vol. 24 (2) , 356-361
Abstract
OBJECTIVE— In Chinese populations, hypertension is common and is a major risk factor for cerebrovascular and coronary heart disease, particularly when associated with diabetes. The clustering of these disorders and dyslipidemia and obesity is termed the metabolic syndrome and is increasing in prevalence in the populations of modernizing Asian nations. The renin-angiotensin system (RAS) helps maintain blood pressure and salt homeostasis and may play a role in the pathogenesis of aspects of the metabolic syndrome. We investigated three RAS gene polymorphisms—the ACE insertion/deletion (I/D), angiotensinogen (AGT) M235T, and angiotensin II type 1 receptor (AT1R) A1166C polymorphisms—for a possible role in modulating these disorders in 853 Chinese subjects with varying components of the metabolic syndrome. RESEARCH DESIGN AND METHODS— The three gene polymorphisms of this crosssectional study were detected using polymerase chain reaction—based protocols. The genotype frequencies were compared between the controls (n = 119) and both overlapping and nonoverlapping groups of patients with type 2 diabetes, hypertension, and dyslipidemia using χ2 test. Differences in levels of the biochemical parameters between the genotypes were determined using analysis of variance. RESULTS— No significant relationship was identified between these polymorphisms and blood pressure in this population. Although the AT1RA1166C polymorphism was not associated with any aspect of the metabolic syndrome examined, there was limited evidence to suggest that the AGT M235T polymorphism may be associated with cholesterol levels. The ACE I allele was significantly more frequent in each group comprising subjects with type 2 diabetes/glucose intolerance (GIT), and the I allele was associated with higher fasting plasma glucose levels. CONCLUSIONS— These findings suggest that these polymorphisms are unlikely to be involved in the pathogenesis of hypertension. The ACE I/D polymorphism was associated with the metabolic syndrome, having a higher frequency of I allele—containing genotypes in those groups, but this appeared to result predominantly from the relationship with type 2 diabetes/GIT in this population of Chinese subjects.Keywords
This publication has 43 references indexed in Scilit:
- Association Between the Angiotensinogen 235T-Variant and Essential Hypertension in WhitesHypertension, 1997
- The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressureArchives of internal medicine (1960), 1997
- Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)The Lancet, 1997
- Antihypertensive and Anti-Albuminuric Effects of Losartan Potassium and Felodipine in Chinese Elderly Hypertensive Patients with or without IMon-lnsulin-Dependent Diabetes mellitusAmerican Journal of Nephrology, 1997
- Insulin-Resistant Lipolysis in Abdominally Obese Hypertensive IndividualsHypertension, 1996
- Clinical review 79: Angiotensin II: an insulin-sensitizing vasoactive hormone?The Journal of Clinical Endocrinology & Metabolism, 1996
- Relations Between Deletion Polymorphism of the Angiotensin-Converting Enzyme Gene and Insulin Resistance, Glucose Intolerance, Hyperinsulinemia, and DyslipidemiaArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension.Hypertension, 1994
- Insulin and the Renin-Angiotensin-Aldosterone SystemJournal of Cardiovascular Pharmacology, 1994
- Absence of linkage between the angiotensin converting enzyme locus and human essential hypertensionNature Genetics, 1992